China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Third-Generation TKI with or without Radiotherapy for Advanced EGFR-Mutant NSCLC?'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132219
Registration Time: 2026/09/10
Type: Observational study
Primary Sponsor: The Second Affiliated Hospital of Hainan Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342838
Published by HT Digital Content Services with permission from Health Daily Digest....